Literature DB >> 9034333

Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis.

C Desaintes1, C Demeret, S Goyat, M Yaniv, F Thierry.   

Abstract

The papillomavirus E2 protein plays a central role in the viral life cycle as it regulates both transcription and replication of the viral genome. In this study, we showed that transient expression of bovine papillomavirus type 1 or human papillomavirus type 18 (HPV18) E2 proteins in HeLa cells activated the transcriptional activity of p53 through at least two pathways. The first one involved the binding of E2 to its recognition elements located in the integrated viral P105 promoter. E2 binding consequently repressed transcription of the endogenous HPV18 E6 oncogene, whose product has been shown previously to promote p53 degradation. The second pathway did not require specific DNA binding by E2. Expression of E2 induced drastic physiological changes, as evidenced by a high level of cell death by apoptosis and G1 arrest. Overexpression of a p53 trans-dominant-negative mutant abolished both E2-induced p53 transcriptional activation and E2-mediated G1 growth arrest, but showed no effect on E2-triggered apoptosis. These results suggest that the effects of E2 on cell cycle progression and cell death follow distinct pathways involving two different functions of p53.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9034333      PMCID: PMC1169654          DOI: 10.1093/emboj/16.3.504

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  A transcriptionally active DNA-binding site for human p53 protein complexes.

Authors:  W D Funk; D T Pak; R H Karas; W E Wright; J W Shay
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

Review 3.  The papillomavirus E2 protein: a factor with many talents.

Authors:  J Ham; N Dostatni; J M Gauthier; M Yaniv
Journal:  Trends Biochem Sci       Date:  1991-11       Impact factor: 13.807

4.  Oncogenic forms of p53 inhibit p53-regulated gene expression.

Authors:  S E Kern; J A Pietenpol; S Thiagalingam; A Seymour; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

5.  Wild-type p53 activates transcription in vitro.

Authors:  G Farmer; J Bargonetti; H Zhu; P Friedman; R Prywes; C Prives
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

6.  Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins.

Authors:  C M Chiang; M Ustav; A Stenlund; T F Ho; T R Broker; L T Chow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

7.  Transient replication of human papillomavirus DNAs.

Authors:  A M Del Vecchio; H Romanczuk; P M Howley; C C Baker
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

8.  Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization.

Authors:  M Dürst; D Glitz; A Schneider; H zur Hausen
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

9.  Cell type-specific inhibition of p53-mediated apoptosis by mdm2.

Authors:  Y Haupt; Y Barak; M Oren
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

10.  Several different upstream promoter elements can potentiate transactivation by the BPV-1 E2 protein.

Authors:  J Ham; N Dostatni; F Arnos; M Yaniv
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  77 in total

1.  The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.

Authors:  F Stubenrauch; T Zobel; T Iftner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells.

Authors:  Allison H S Hall; Kenneth A Alexander
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Induction of apoptosis by the transcription factor c-Jun.

Authors:  E Bossy-Wetzel; L Bakiri; M Yaniv
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

4.  HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.

Authors:  Phillip R Heaton; Adeline F Deyrieux; Xue-Lin Bian; Van G Wilson
Journal:  Virus Res       Date:  2011-04-12       Impact factor: 3.303

5.  Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein.

Authors:  Jasmin Fertey; José Hurst; Elke Straub; Astrid Schenker; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

6.  Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.

Authors:  Monique A Morrison; Richard J Morreale; Shailaja Akunuru; Matthew Kofron; Yi Zheng; Susanne I Wells
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

7.  The Antiproliferative Effect of the "Early" Protein E2 of Papillomavirus HPV16 on Testis Tumors of Mice Induced by the Injection of HeLa Cells.

Authors:  R K Salyaev; N I Rekoslavskaya; A S Stolbikov
Journal:  Dokl Biochem Biophys       Date:  2019-11-25       Impact factor: 0.788

8.  HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.

Authors:  Anna Manawapat-Klopfer; Lisa Wang; Juliane Haedicke-Jarboui; Frank Stubenrauch; Christian Munk; Louise T Thomsen; Peter Martus; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

9.  The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.

Authors:  Marc A Schneider; Konstanze D Scheffer; Timo Bund; Fatima Boukhallouk; Carsten Lambert; Cristina Cotarelo; Gert O Pflugfelder; Luise Florin; Gilles A Spoden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity.

Authors:  Isabelle Bouallaga; Sébastien Teissier; Moshe Yaniv; Françoise Thierry
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.